A 70-year-old man with NIDDMwas diagnosed as having renovascular hypertension (RVH), based on a stenosis of the ostial portion of the left renal artery with markedly elevated plasma renin activity (PRA) in both the left renal vein and the peripheral blood, and positive captopril tests. After percutaneous transluminal renal angioplasty (PTRA), his blood pressure (BP) and PRA normalized. However, since restenosis occurred three monthslater, stent therapy was applied, and consequently BP and PRAnormalized immediately after this procedure. During the one-year follow-up, side effects have not been noted. Wepropose that stent therapy may be feasible for ostial renal artery stenosis in elderly diabetic patients.
Introduction
Renovascular hypertension (RVH)is one of the etiologies of secondary hypertension, and is found in about 1%of the entire hypertensive population (1) (2) (3) . In such cases, a surgical procedure has generally been performed. In 1978, Griintzig et al (4) first introduced percutaneous transluminal renal angioplasty (PTRA) for RVHdue to renal arterial stenosis. This technique has been used widely because of its effectiveness, safety and low cost as compared with surgical revasculizations (5, 6) . However, it was recently pointed out that PTRAmight be less effective in cases of RVHdue to ostial stenosis of the renal artery because of the relatively high incidence of restenosis (6) .
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Angioplasty with balloon expansion and stent implantation, which was used for coronary arterial diseases (7) , was first applied for RVHin 1991 (8) . Since then, angioplasty with stent implantation has been considered to be more successful than PTRAalone and decreased postoperative restenosis (9-1 1). With regard to the effectiveness of stent implantation on RVH, there are only a few reports in Japan (12) (13) (14) (15) (16) , while manystudies have been conducted in other countries (9-1 1). Wereport here on an aged patient with diabetes mellitus in whomrestenosis occurred three months after PTRAfor RVH due to left renal arterial stenosis, and subsequent angioplasty with stent implantation was performed successfully.
Case Report
A 70-year-old manwas admitted to our hospital because of vertigo on February ll, 1998. He had been treated for hypertension and diabetes mellitus at a local clinic for the past 20 years. On admission, physical examination showed a height of 169 cm, body weight of65 kg, and BP of 160/104 mmHgwith a regular pulse rate of 60 beats/min. Fundoscopy revealed hypertensive and sclerotic changes, and diabetic retinopathy classified as Scheie Ho Si and Scott 0, respectively. His knee jerk was decreased. Abdominal bruit was not audible. The routine laboratory data were as follows: normal total cholesterol ( 180 mg/dl), low HDL-cholesterol (27 mg/dl), and high fasting blood glucose (301 mg/dl) and HbAlc (9.0%). Coagulation parameters were within the normal ranges. The 24-hour urinary albumin excretion rate was 10.5 |Lig/min. The glomerular filtration rate (GFR) was 67.7 ml/min, indicating mild renal dysfunction. The remainder of the laboratory data were unremarkable.
Electrocardiogram was normal. Renogramshowedslight deterioration in bilateral renal function (Fig. 1A) . On abdominal computed tomography, no difference in kidney size was observed, but atherosclerotic changes in the abdominal aorta were present. The basal level of plasma renin activity (PRA) was elevated (4.8 ng/ml/h), and markedly responded to 10.0 ng/ml/h during a furosemide test (80 mg furosemide plus 4-hour upright posture). In a captopril test (25 mg captopril per orally administrated), the PRAwas elevated from 3.9 to 51.4 ng/ml/h. In a renogram performed simultaneously during this Stent Implantation for RVH test, the difference in the bilateral renal blood flow became marked (17) , and depression in the left renal function was revealed ( Fig. IB) . Renal angiography showed approximately 80% ostial stenosis in the left renal artery (Fig. 2) . Selective renal venous sampling revealed a marked elevation in PRA obtained from the left renal vein (2.9 ng/ml/h) as compared with the right side (1. 1 ng/ml/h): the left to right ratio was 2.6, suggesting renin release from the left kidney. Thus, we diagnosed RVHdue to the left renal artery stenosis. PTRA was performed on May 6, 1998, resulting in improvement of the previously stenotic lesion of the left renal artery. Within 30 minutes of PTRA, BP level normalized to 120/72 mmHg. He was maintained without any anti-hypertensive drugs and discharged in 10 days. On August 14, three months after angioplasty, he was readmitted because of vertigo and headache with an increase in BP to 168/100 mmHgaccompaning the elevated PRA(5.9 ng/ml/h). Angiography revealed restenosis in the same region, showing a diameter of 1.0 mm and length of 7.3 mm, which was 0.5 mmdistance from the origin of the aortic trunk. For the treatment of this restenosis lesion, we selected PTRAwith stent implantation. One Palmaz vascular stent (Johnson and Johnson Co, Warren, NJ, USA) was implanted in the ostial region of the main artery and the other in a branched artery in which mild stenosis continuing from main artery was recognized (Fig. 3) . After the procedure, the patient was administered 300 mg of ticlopidine, an anticoagulant drug. One year after the therapy, he still has normal PRA and normal BP without any antihypertensive drugs.
Discussion
The present case of RVHshowed a stenosis of 80%at the was effective for the diagnosis of RVH,and the underlying mechanismwas thought to be as follows: the GFRof an affected kidney is dependent on the effects of angiotensin II on the efferent glomerular arterioles, so that inhibition of angiotensin converting enzyme produces a marked decrease in GFR. However, the changes in renal blood flow at the other side are less pronounced. Therefore, the characteristic effect of captopril in a kidney with a renal artery stenosis causes a decreased DTPA uptake (17) as observed in Fig. IB . Although we initially considered surgical revascularization in the present case, as previous reports (1, 5-7), PTRAwas first chosen due to less invasiveness. After the PTRA, the stenotic region was expanded, and hyperreninemia as well as hypertension improved promptly. However, three months later, the PRAincreased again and hypertension recurred with restenosis in the sameregion on angiograms.Therefore, we performed angioplasty with a stent implantation. Those abnormal findings improved rapidly, and the PRAand BP has remained within the normal range to date, one year after PTRA with stent implantations. Thus, this treatment was considered to have been successful in our case. In cases with markedstenosis and an increase in renin release from the affected kidney, the risk of vascular complications or renal dysfunction is high, and PTRAhas been thus performed (18) . Since the first application of PTRAfor the treatment of RVHin 1978 (4), PTRA, which is simpler, safer, and less expensive than surgical revascularization, has been used widely for the last 20 years. However, in patients who underwent PTRAfor renal arterial stenosis caused by atherosclerosis, a high incidence of fatal complications such as cholesterol thrombosis (19, 20) , rupture of the renal artery, renal arterial thrombosis, segmented renal infarction, hematoma, and myocardial infarction (19) , have been reported as adverse events. Furthermore, a high rate of restenosis (35-65%) within about six months to one year after PTRAwas reported (19, 21) . Thus, although PTRAis safer than surgical procedure, stenosis recurs at a higher rate and its long-term effectiveness has been questioned (19, 21) . Recently, various types of stents, including Palmaz stents, have been used widely for angioplasty in coronary arterial diseases (7). However, for angioplasty in RVHonly a few studies (12) (13) (14) (15) (16) (Table 1 ) have been reported in Japan. Various reasons are conceivable for this situation. First, the medical insurance has only covered a stent implantation therapy for RVHsince 1997. Secondly, with regard to racial difference Japanese have less degree of hyperinsulinemia and hyperlipidemia compared with American (22) . In fact, the frequencies of various vascular events differ amongraces (23) . Finally, stent therapy requires special skill. Since Palmaz stents were first implanted for patients with RVHin 1991 (8), prognostic data have been reported: i.e. the incidence of restenosis was about 16% (9, 10, 24) , which was less than that in PTRA alone. As compared with surgical treatment, the treatment with stent was demonstrated to be technically less risky and to be equivalent in protection of renal blood flow and reduction in BP. Moreover, in a non-discriminative comparison study (25) on PTRAand treatment with stents limited to ostial atherosclerotic renovascular lesions, the PTRAwith stents showed a significantly lower incidence of restenosis even in long-term observation than PTRAalone (25) , suggesting that the treatment with stent is the first choice for initial angioplasty (25) .
In the present case, we conducted anti-coagulant therapy with the some protocol used after treatment with stents for ischemic cardiac disease (26) . However, it has not yet been established what type of anti-coagulant therapy is needed as a countermeasureagainst restenosis after treatment with stents in the renal artery. Moreover, it is necessary to define the further roles of treatment with stents, taking into consideration of the Japanese characteristics of lesions and the risk factors of individual patients such as advanced age or diabetes mellitus. In addition, multi-institutional analysis in Japan will be necessary to evaluate the role of stent implantation for RVH.
